SciLifeLab voices: Margit Mahlapuu

Meet Margit Mahlapuu (GU), our new DDLS Cell & Molecular Biology Research Area Lead. She succeeded Erik Lindahl (SU) in July 2023, bringing new experience and a fresh perspective to the role.

Hello, Margit! Could you briefly describe your research?

The focus of my research is to combine studies in unique mouse models and well-characterized human cohorts with in vitro assays, to provide insight into molecular pathogenesis, and to find novel treatments and/or preventive strategies for type 2 diabetes (T2D), liver disease MASH, and related complex metabolic diseases with high unmet medical need.

How do you think your expertise can contribute to the DDLS program?

I believe that my translational background in academic research, but also in drug discovery and development in the pharma and biotech sector, will be a valuable asset to contribute to the DDLS program. Our expert group, representing a broad expertise in this complex subject field, will advise DDLS leadership in terms of research area-specific strategies and will also assist DDLS Data Science Node in shaping their scientific profile and priorities.

The mission of the DDLS program is to act at the global research front-line and have societal impact, could you give an example of that from your own field?

In the field of cell and molecular biology, and in my own research field specifically, the mechanistic studies that help us understand the molecular pathogenesis of diseases are instrumental. This understanding aids in the development of curative and affordable therapies to improve both the physical and mental health of individuals.

What are you looking forward to this year?

In relation to DDLS, this will be a very interesting year. New DDLS Fellows are being recruited and will start their research activities, and the DDLS research school for PhD students will be launched. Importantly, the newly recruited fellows and their team members will be integrated with the existing DDLS community and with other Wallenberg Foundation-funded programs such as WCMTM, contributing to a large and rapidly growing trans-disciplinary network with intensive collaborations.

What was the last book you read or the last movie you watched?

I accompanied my son to see Kung Fu Panda 4, which was a very interesting movie elaborating on the importance of educating the next generation of leaders and the speed of trust.

Photo: Johan Wingborg

Short background

Margit has a diverse background in both academia and industry, having worked at AstraZeneca, Arexis, Biovitrum, PharmaSurgics, and Pergamum. Since 2019, she has been a Professor in Molecular Genetics at the Department of Chemistry and Molecular Biology at the University of Gothenburg.

During 2022-2023, Margit was a visiting professor at the Lipid Metabolism Laboratory, Charles Perkins Centre, University of Sydney, Australia, for four months. Today, in addition to her role as DDLS Research Area Lead, Margit serves as Co-Director of the Wallenberg Centre for Molecular and Translational Medicine (WCMTM) at the University of Gothenburg. Wingborg


Last updated: 2024-05-23

Content Responsible: Johan Inganni(